CLPT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLPT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ClearPoint Neuro's enterprise value is $435.50 Mil. ClearPoint Neuro's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $30.43 Mil. Therefore, ClearPoint Neuro's EV-to-Revenue for today is 14.31.
The historical rank and industry rank for ClearPoint Neuro's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of ClearPoint Neuro was 38.12. The lowest was 0.54. And the median was 6.49.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-12-12), ClearPoint Neuro's stock price is $16.4359. ClearPoint Neuro's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $1.16. Therefore, ClearPoint Neuro's PS Ratio for today is 14.21.
The historical data trend for ClearPoint Neuro's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClearPoint Neuro Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 6.23 | 21.43 | 13.73 | 8.89 | 6.60 |
ClearPoint Neuro Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EV-to-Revenue | Get a 7-Day Free Trial | 5.07 | 6.60 | 6.31 | 4.62 | 9.58 |
For the Medical Devices subindustry, ClearPoint Neuro's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
ClearPoint Neuro's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 435.501 | / | 30.429 | |
= | 14.31 |
ClearPoint Neuro's current Enterprise Value is $435.50 Mil.
ClearPoint Neuro's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $30.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClearPoint Neuro (NAS:CLPT) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
ClearPoint Neuro's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 16.4359 | / | 1.157 | |
= | 14.21 |
ClearPoint Neuro's share price for today is $16.4359.
ClearPoint Neuro's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of ClearPoint Neuro's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lynnette C Fallon | director | 108 CHERRY HILL DRIVE, BEVERLY MA 01915 |
Linda M. Liau | director | 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075 |
Mazin Sabra | officer: Chief Operating Officer | 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075 |
Joseph Michael Burnett | director, officer: CEO and President | C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618 |
L. Jeremy Stigall | officer: GM, Biologics & Drug Delivery | 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075 |
Danilo D'alessandro | officer: Vice President, Finance | 5 MUSICK, IRVINE CA 92618 |
Harold A Hurwitz | officer: Chief Financial Officer | |
R John Fletcher | director | C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070 |
Girin Pascal E R | director | C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618 |
B Kristine Johnson | director | 366 FERNDALE RD S, WAYZATA MN 55391 |
Timothy T. Richards | director | ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103 |
Matthew B. Klein | director | C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080 |
Marcio Souza | director | C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080 |
Voyager Therapeutics, Inc. | 10 percent owner | 75 HAYDEN AVENUE, LEXINGTON MA 02421 |
Wendelin C Maners | officer: Vice President, Marketing | ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103 |
From GuruFocus
By GuruFocus Research • 05-08-2024
By GlobeNewswire • 06-01-2024
By Marketwired • 06-01-2024
By GuruFocus News • 11-08-2024
By PRNewswire • 06-20-2024
By GuruFocus Research • 05-07-2024
By ACCESSWIRE • 11-08-2024
By GuruFocus News • 11-05-2024
By GuruFocus News • 10-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.